Ftse Mib
33.887,05
0,62%
DAX
18.996,63
0,89%
S&P 500
5.726,79
0,14%
NASDAQ
18.051,68
0,43%
Bitcoin
63.722,12
0,62%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Exscientia PLC (EXAI) Exscientia PLC (EXAI) Notizie

EXAI

Exscientia (EXAI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EXAI
DataOraFonteTitoloSimboloCompagnia
30/08/202414:57Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:EXAIExscientia PLC
28/08/202422:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
28/08/202418:11Business WireExscientia wird auf der 22nd Annual Global Healthcare Conference Präsentation durchführenNASDAQ:EXAIExscientia PLC
28/08/202418:11Business WireExscientia participera à la 22e conférence annuelle de Morgan Stanley sur les soins médicaux dans le mondeNASDAQ:EXAIExscientia PLC
28/08/202413:00Business WireExscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:EXAIExscientia PLC
23/08/202422:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
15/08/202413:00Business WireExscientia Business Update for Second Quarter and First Half 2024NASDAQ:EXAIExscientia PLC
09/08/202411:44IH Market NewsTSMC July Revenue Surges 45%, Nasdaq Accelerates Penny Stock Delistings, Moody’s Downgrades Intel to BAA1, and MoreNASDAQ:EXAIExscientia PLC
08/08/202413:39GlobeNewswire Inc.Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End CapabilitiesNASDAQ:EXAIExscientia PLC
18/07/202418:36Business WireExscientia erwirbt volle Rechte an potenziellem CDK7-Inhibitor der Spitzenklasse vor der Veröffentlichung von Phase-1-Dosis-EskalationsdatenNASDAQ:EXAIExscientia PLC
18/07/202416:20Business WireExscientia acquiert les droits complets d’un inhibiteur potentiel de CDK7, le meilleur de sa catégorie, avant la publication des données de dose croissante de phase 1NASDAQ:EXAIExscientia PLC
18/07/202413:00Business WireExscientia Acquires Full Rights to Potential Best-in-Class CDK7 Inhibitor Ahead of Phase 1 Dose Escalation Data ReadoutNASDAQ:EXAIExscientia PLC
10/07/202423:44Business WireExscientia lance une plateforme AWS optimisée par l'IA pour promouvoir la découverte de médicamentsNASDAQ:EXAIExscientia PLC
10/07/202421:13Business WireExscientia bringt KI-gestützte AWS-Plattform zur Verbesserung der Arzneimittelforschung auf den MarktNASDAQ:EXAIExscientia PLC
10/07/202413:00Business WireExscientia Launches AWS AI-powered Platform to Advance Drug DiscoveryNASDAQ:EXAIExscientia PLC
25/06/202411:45PR Newswire (US)EXAI LAWSUIT ALERT: The Gross Law Firm Notifies Exscientia plc Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:EXAIExscientia PLC
20/06/202411:45PR Newswire (US)Exscientia plc Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
17/06/202411:45PR Newswire (US)Shareholders that lost money on Exscientia plc(EXAI) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:EXAIExscientia PLC
10/06/202411:45PR Newswire (US)June 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EXAINASDAQ:EXAIExscientia PLC
06/06/202422:16Business WireExscientia ernennt neue Führungskräfte zur Stärkung der Auswirkungen integrierter Technologien und um den Schwerpunkt auf klinische Entwicklungskompetenz in der Onkologie zu richtenNASDAQ:EXAIExscientia PLC
06/06/202421:49Business WireExscientia nomme de nouveaux dirigeants pour accentuer l'impact des technologies intégrées et recentrer l'expertise en développement clinique sur l'oncologieNASDAQ:EXAIExscientia PLC
06/06/202413:00Business WireExscientia Appoints New Leaders to Strengthen the Impact of Integrated Technologies and Focus Clinical Development Expertise in OncologyNASDAQ:EXAIExscientia PLC
05/06/202411:45PR Newswire (US)Shareholders that lost money on Exscientia plc(EXAI) should contact The Gross Law Firm about pending Class Action - EXAINASDAQ:EXAIExscientia PLC
30/05/202420:30Business WireExscientia participera à des conférences d'investisseurs au mois de juinNASDAQ:EXAIExscientia PLC
30/05/202419:58Business WireExscientia präsentiert sich auf kommenden Investorenkonferenzen im JuniNASDAQ:EXAIExscientia PLC
30/05/202413:00Business WireExscientia to Present at Upcoming Investor Conferences in JuneNASDAQ:EXAIExscientia PLC
29/05/202411:45PR Newswire (US)Exscientia plc Sued for Securities Law Violations - Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
21/05/202413:00Business WireExscientia Business Update for First Quarter 2024NASDAQ:EXAIExscientia PLC
21/05/202411:45PR Newswire (US)Shareholders of Exscientia plc Should Contact The Gross Law Firm Before June 25, 2024 to Discuss Your Rights - EXAINASDAQ:EXAIExscientia PLC
14/05/202421:52Business WireExscientia legt am 21. Mai 2024 das Geschäftsergebnis für das erste Quartal 2024 vorNASDAQ:EXAIExscientia PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:EXAI

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
MONC
Moncler
BIT
SPM
Saipem
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network